Stryker Corp (NYSE: SYK) kicked off on Tuesday, down -1.30% from the previous trading day, before settling in for the closing price of $394.69. Over the past 52 weeks, SYK has traded in a range of $314.93-$406.19.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 8.96% over the last five years. While this was happening, its average annual earnings per share was recorded 9.52%. With a float of $357.49 million, this company’s outstanding shares have now reached $382.10 million.
The firm has a total of 53000 workers. Let’s measure their productivity. In terms of profitability, gross margin is 63.57%, operating margin of 15.77%, and the pretax margin is 14.36%.
Stryker Corp (SYK) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Stryker Corp is 6.46%, while institutional ownership is 80.52%. The most recent insider transaction that took place on May 12 ’25, was worth 482,202. In this transaction VP, Chief Accounting Officer of this company sold 1,241 shares at a rate of $388.56, taking the stock ownership to the 2,833 shares. Before that another transaction happened on May 12 ’25, when Company’s Officer proposed sale 1,241 for $388.56, making the entire transaction worth $482,197.
Stryker Corp (SYK) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 3.12 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 9.52% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.85% during the next five years compared to 7.20% growth over the previous five years of trading.
Stryker Corp (NYSE: SYK) Trading Performance Indicators
Take a look at Stryker Corp’s (SYK) current performance indicators. Last quarter, stock had a quick ratio of 1.00. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.41. Likewise, its price to free cash flow for the trailing twelve months is 41.62.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 7.41, a number that is poised to hit 3.07 in the next quarter and is forecasted to reach 14.84 in one year’s time.
Technical Analysis of Stryker Corp (SYK)
Analysing the last 5-days average volume posted by the [Stryker Corp, SYK], we can find that recorded value of 1.09 million was lower than the volume posted last year of 1.57 million. As of the previous 9 days, the stock’s Stochastic %D was 86.91%. Additionally, its Average True Range was 8.49.
During the past 100 days, Stryker Corp’s (SYK) raw stochastic average was set at 78.40%, which indicates a significant decrease from 83.13% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 15.14% in the past 14 days, which was lower than the 25.93% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $368.60, while its 200-day Moving Average is $369.07. Now, the first resistance to watch is $392.58. This is followed by the second major resistance level at $395.62. The third major resistance level sits at $397.91. If the price goes on to break the first support level at $387.25, it is likely to go to the next support level at $384.96. Now, if the price goes above the second support level, the third support stands at $381.92.
Stryker Corp (NYSE: SYK) Key Stats
The company with the Market Capitalisation of 148.87 billion has total of 381,689K Shares Outstanding. Its annual sales at the moment are 22,595 M in contrast with the sum of 2,993 M annual income. Company’s last quarter sales were recorded 5,866 M and last quarter income was 654,000 K.